← Stocks · TCRT record
Signal record & history · Trifecta Signals
Alaunos has been flagged by the Trifecta screener 1 time since 2022. 1 signal confirmed; the median confirmed signal is down 99.0% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Oct 2022 · Latest Oct 2022 · Confirmed 1 of 1 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since October 2022, Alaunos has had one Early signal, one confirmed. Its one decided signal did not reach +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for TCRT and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Alaunos Therapeutics is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. With a market value of about $7.7 million, the company falls in the small-cap group.
Alaunos Therapeutics’ standout Trifecta run followed a October 2022 confirmation, falling about 38% over the next 90 days. For classification, its latest signal was rated Low Quality, and it sat in the large-cap group when that signal fired.
At the most recent close, Wednesday, November 4, the shares finished at $1.80, down 3.2% on the day. Over the past week, the shares have traded in a range between about $1.75 and $1.95.
